• Rothe@piefed.social
    link
    fedilink
    English
    arrow-up
    2
    ·
    3 days ago

    At the cost of a shitload of snus though, so not really as impressive as it sounds.

    • mastertigurius@lemmy.world
      link
      fedilink
      arrow-up
      1
      ·
      3 days ago

      I was about to say the same thing. Norway is also overflowing with snus (much of it from Sweden), and I don’t think it brings any significant health benefits compared to smoking.

      • dbdr@nord.pub
        link
        fedilink
        English
        arrow-up
        2
        ·
        3 days ago

        Oct. 22, 2019 /PRNewswire/ – The U.S. Food and Drug Administration announced today that, for the first time, it has authorized the marketing of products through the modified risk tobacco product (MRTP) pathway. The authorizations are for eight Swedish Match USA, Inc. snus smokeless tobacco products sold under the “General” brand name.

        These products had previously been authorized for U.S. sale without modified risk claims by the FDA in 2015 in response to filings of premarket tobacco applications (PMTAs). Today’s action further authorizes the manufacturer to market these specific products with the claim “Using General Snus instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” The FDA made this authorization after reviewing scientific evidence submitted by the company that supports this claim. In an effort to help prevent youth access and exposure, the agency has also placed stringent advertising and promotion restrictions on the products, including a requirement to restrict advertising to adults. In addition, the products’ packaging and advertising must also bear the warning statements required for all smokeless tobacco products.